{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:40:48Z","timestamp":1795059648362,"version":"4.10.2"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":427,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"KG Jebsen Center for Cardiac Research"},{"name":"Oslo New University College"},{"DOI":"10.13039\/501100006133","name":"Anders Jahres fond til vitenskapens fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020210","name":"Olav Raagholt og Gerd Meidel Raagholts stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011076","name":"Simon Fougner Hartmanns Family Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011076","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rakel og Otto Kristian Bruun's Legat"},{"DOI":"10.13039\/501100006133","name":"Anders Jahres Fond til Vitenskapens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020210","name":"Olav Raagholt og Gerd Meidel Raagholts stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011076","name":"Simon Fougner Hartmanns Familiefond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Sacubitril\/valsartan (Sac\/Val) is used for treatment of heart failure. The effect of Sac\/Val on regional dysfunction following myocardial infarction (MI) remains uncertain. This study aimed at understanding the effects of Sac\/Val on regional function after MI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>MI or sham surgery was performed in Sprague\u2013Dawley rats. Animals were randomized to treatment with Sac\/Val, valsartan (Val) or vehicle (Veh). Magnetic resonance imaging was used to acquire left ventricular volumes and strain. Left ventricular tissue was obtained for wesern blotting, PCR and Masson's trichrome staining. Isolated cardiac fibroblasts were cultured with Veh, atrial natriuretic peptide (ANP), adrenomedullin (ADM) and sacubitrilat, and collagen expression assessed with droplet digital PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sac\/Val reduced ventricular end-diastolic volume by 18% compared with Veh, and preserved circumferential systolic strain in the zone proximal to infarction compared with sham after 42 days of treatment (peak strain \u00b1 SEM: sham: \u22120.19 \u00b1 0.01%; Sac\/Val: \u22120.14 \u00b1 0.02%; Val: \u22120.10 \u00b1 0.02%; Veh: \u22120.10 \u00b1 0.02%). Masson's trichrome staining demonstrated lower fibrotic deposition in the intermediate zone with Sac\/Val treatment than Veh (sham: 2.29 \u00b1 0.17%; Sac\/Val: 2.31 \u00b1 0.27%; Val: 3.22 \u00b1 0.60%; Veh: 4.14 \u00b1 0.48%). The amounts of the pro-apoptotic caspase 3 cleavage fragments p19\/17 were 89% higher in Val than sham, with Sac\/Val showing no significant increase compared with sham. Collagen expression in human fibroblast culture was lower in cells co-treated with sacubitrilat and ANP, an effect not observed with sacubitrilat\/ADM co-treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sac\/Val preserves in vivo myocardial function in the region most proximal to MI in rats and reduces left ventricular dilatation. These effects may be related to a reduction in both fibrosis and pro-apoptotic signalling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15145","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T01:41:33Z","timestamp":1734572493000},"page":"1304-1315","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sacubitril\/Valsartan Preserves Regional Cardiac Function Following Myocardial Infarction in Rats"],"prefix":"10.1093","volume":"12","author":[{"given":"Einar Sjaastad","family":"Nord\u00e9n","sequence":"first","affiliation":[{"name":"University of Oslo, Oslo University Hospital and Oslo New University College , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e5rd Andre","family":"Bendiksen","sequence":"additional","affiliation":[{"name":"University of Oslo, Oslo University Hospital and Oslo New University College , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja Knudsen","family":"Bergo","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil Knut Stenersen","family":"Espe","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"McGinley","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almira","family":"Hasic","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Marie","family":"Hauge-Iversen","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Katrin","family":"Ugland","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shen","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Frisk","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishani S.","family":"Mabotuwana","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Louch","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan I.","family":"Hussain","sequence":"additional","affiliation":[{"name":"Agiana Pharmaceuticals AS , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivar","family":"Sjaastad","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cataliotti","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Christensen","sequence":"additional","affiliation":[{"name":"University of Oslo and Oslo University Hospital , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"2026021803583414500_ehf215145-bib-0001","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026021803583414500_ehf215145-bib-0002","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2026021803583414500_ehf215145-bib-0003","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"2026021803583414500_ehf215145-bib-0004","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"Angiotensin receptor\u2013neprilysin inhibition in acute myocardial infarction","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021803583414500_ehf215145-bib-0005","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.amjcard.2020.12.037","article-title":"Comparison of the efficacy and safety of sacubitril\/valsartan versus ramipril in patients with ST-segment elevation myocardial infarction","volume":"143","author":"Rezq","year":"2021","journal-title":"Am J Cardiol"},{"key":"2026021803583414500_ehf215145-bib-0006","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1038\/s41598-019-42113-0","article-title":"Angiotensin receptor neprilysin inhibitor attenuates myocardial remodeling and improves infarct perfusion in experimental heart failure","volume":"9","author":"Pfau","year":"2019","journal-title":"Sci Rep"},{"key":"2026021803583414500_ehf215145-bib-0007","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.jacc.2018.07.102","article-title":"Sacubitril\/valsartan averts adverse post-infarction ventricular remodeling and preserves systolic function in rabbits","volume":"72","author":"Torrado","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026021803583414500_ehf215145-bib-0008","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015640","article-title":"Sacubitril\/valsartan improves cardiac function and decreases myocardial fibrosis via downregulation of exosomal miR-181a in a rodent chronic myocardial infarction model","volume":"9","author":"Vaskova","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026021803583414500_ehf215145-bib-0009","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","article-title":"Left ventricular remodeling after myocardial infarction","volume":"101","author":"Sutton","year":"2000","journal-title":"Circulation"},{"key":"2026021803583414500_ehf215145-bib-0010","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/10976640600723664","article-title":"How to perform an accurate assessment of cardiac function in mice using high-resolution magnetic resonance imaging","volume":"8","author":"Schneider","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026021803583414500_ehf215145-bib-0011","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2342-10-1","article-title":"Design and validation of segment--freely available software for cardiovascular image analysis","volume":"10","author":"Heiberg","year":"2010","journal-title":"BMC Med Imaging"},{"key":"2026021803583414500_ehf215145-bib-0012","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005997","article-title":"Regional dysfunction after myocardial infarction in rats","volume":"10","author":"Espe","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026021803583414500_ehf215145-bib-0013","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6652","article-title":"IOCBIO Sparks detection and analysis software","volume":"7","author":"Laasmaa","year":"2019","journal-title":"PeerJ"},{"key":"2026021803583414500_ehf215145-bib-0014","doi-asserted-by":"publisher","first-page":"H958","DOI":"10.1152\/ajpheart.00279.2018","article-title":"Regional and temporal changes in left ventricular strain and stiffness in a porcine model of myocardial infarction","volume":"315","author":"Torres","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026021803583414500_ehf215145-bib-0015","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9040906","article-title":"Sacubitril\/valsartan induces global cardiac reverse remodeling in long-lasting heart failure with reduced ejection fraction: standard and advanced echocardiographic evidences","volume":"9","author":"Castrichini","year":"2020","journal-title":"J Clin Med"},{"key":"2026021803583414500_ehf215145-bib-0016","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ehf2.12656","article-title":"Short-term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril\/valsartan","volume":"7","author":"Mazzetti","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026021803583414500_ehf215145-bib-0017","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/circheartfailure.114.001785","article-title":"Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy","volume":"8","author":"von Lueder","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2026021803583414500_ehf215145-bib-0018","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.122.059210","article-title":"Impact of sacubitril\/valsartan compared with ramipril on cardiac structure and function after acute myocardial infarction: the PARADISE-MI echocardiographic substudy","volume":"146","author":"Shah","year":"2022","journal-title":"Circulation"},{"key":"2026021803583414500_ehf215145-bib-0019","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac Fibrosis","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"key":"2026021803583414500_ehf215145-bib-0020","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.123.012517","article-title":"Antiarrhythmic and anti-inflammatory effects of sacubitril\/valsartan on post-myocardial infarction scar","volume":"17","author":"Mart\u00ednez-Falguera","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026021803583414500_ehf215145-bib-0021","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.118.005565","article-title":"Sacubitril\/valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts","volume":"12","author":"Burke","year":"2019","journal-title":"Circ Heart Fail"},{"key":"2026021803583414500_ehf215145-bib-0022","doi-asserted-by":"publisher","first-page":"H2726","DOI":"10.1152\/ajpheart.2001.280.6.H2726","article-title":"Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats","volume":"280","author":"Palojoki","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026021803583414500_ehf215145-bib-0023","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/toxres\/tfac018","article-title":"Sacubitril\/valsartan protects against arsenic trioxide induced cardiotoxicity in vivo and in vitro","volume":"11","author":"Wu","year":"2022","journal-title":"Toxicol Res (Camb)"},{"key":"2026021803583414500_ehf215145-bib-0024","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1136\/heartjnl-2017-311295","article-title":"Sacubitril\/valsartan: beyond natriuretic peptides","volume":"103","author":"Singh","year":"2017","journal-title":"Heart"},{"key":"2026021803583414500_ehf215145-bib-0025","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation\u2013contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"2026021803583414500_ehf215145-bib-0026","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ehf2.13177","article-title":"Sacubitril\/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload","volume":"8","author":"Nord\u00e9n","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026021803583414500_ehf215145-bib-0027","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/ehf2.12918","article-title":"Sacubitrilat reduces pro-arrhythmogenic sarcoplasmic reticulum Ca2+ leak in human ventricular cardiomyocytes of patients with end-stage heart failure","volume":"7","author":"Eiringhaus","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026021803583414500_ehf215145-bib-0028","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1152\/physiol.00021.2012","article-title":"No rest for the weary: diastolic calcium homeostasis in the normal and failing myocardium","volume":"27","author":"Louch","year":"2012","journal-title":"Physiology (Bethesda)"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/2\/1304\/66952929\/eschf_12_2_1304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/2\/1304\/66952929\/eschf_12_2_1304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:58:38Z","timestamp":1771405118000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/2\/1304\/8487948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,12,18]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15145","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"2024-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}